Live Breaking News & Updates on Iagen

Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript

Qiagen N.V. (NYSE:QGEN) Q1 2024 Earnings Call Transcript April 30, 2024 Qiagen N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. I’m Melinda, your PGI call operator. Welcome, and thank you for […]

India , South-korea , Japan , Chicago , Illinois , United-states , San-diego , California , China , Asia-pacific , Thierry-bernard , International-panel-physicians-association

Qiagen N.V. (NYSE:QGEN) is largely controlled by institutional shareholders who own 81% of the company

Key Insights Given the large stake in the stock by institutions, Qiagen's stock price might be vulnerable to their.

Massachusetts , United-states , Blackrock , Blackrock-inc , Vanguard-group-inc , Massachusetts-financial-services-company , Vanguard-group , Institutional-ownership , Wnership-structure , Iagen , Nsider-ownership

Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript

Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript February 11, 2024 Qiagen N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. I’m Melinda, your PGI call operator. Welcome, and thank you for joining Qiagen’s Fourth Quarter 2023 Earnings […]

New-york , United-states , China , Ministry-of-health , Masqat , Oman , Saudi-arabia , Netherlands , America , Thierry-bernard , Powermax-soil-pro-kit , Myriad-genetics

Protein Purification and Isolation Market Trends:

“Protein Purification and Isolation Market” from 2024-2034 with covered segments (Protein Purification and Isolation Market, By Technology.

Italy , India , France , Japan , China , Spain , South-africa , United-states , Russia , United-kingdom , Saudi-arabia , South-korea

The Qiagen N.V. (NYSE:QGEN) Full-Year Results Are Out And Analysts Have Published New Forecasts

Last week saw the newest yearly earnings release from Qiagen N.V. ( NYSE:QGEN ), an important milestone in the.

Earnings-per-share , Evenue-estimates , Iagen , Rowth-estimates , Evenue-growth ,

Monoclonal Antibody Diagnostic Reagents Market Size & Share

“Monoclonal Antibody Diagnostic Reagents Market” from 2024-2034 with covered segments (By Diagnostic Tests (Double Antigen Sandwich Chemiluminescence.

United-kingdom , France , Germany , India , Israel , Mexico , China , Japan , Australia , South-africa , Italy , Brazil

EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase - adhoc - Börsennachrichten

EQSAdhoc QIAGEN NV Key word Share Buyback QIAGEN NV QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase 07Jan2024 1903 CETCEST Disclosure of an inside inf

Netherlands , Frankfurt , Brandenburg , Germany , Venlo , Limburg , Daniele-berheide , John-gilardi , Frankfurt-stock-exchange , Corporate-communications , Annual-general-meeting , Share-premium-reserve

Qiagen N.V. (NYSE:QGEN) is largely controlled by institutional shareholders who own 82% of the company

Key Insights Given the large stake in the stock by institutions, Qiagen's stock price might be vulnerable to their.

Blackrock-inc , Institutional-ownership , Nstitutional-investors , Iagen , Nstitutions , Hareholders , Ndividual-investors , Nsider-ownership ,

Qiagen expands range of digital PCR kits and services for biopharma industry

Qiagen has announced the expansion of its digital PCR (dPCR) offering for the development of cell and gene therapies in the biopharma industry.

David-dobnik , Michael-scheffler , Niba-labs , Vector-lysis-kit , Good-manufacturing-practice , Markets-amp-regulations , Merging-markets , Iagen , Iopharmaceutical , Cell-and-gene-therapy , Anufacturing

QIAGEN expands next-generation sequencing portfolio with QIAseq Normalizer Kits

QIAGEN has announced the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.

Thomas-schweins , Life-sciences-business-area , Product-news , Normalizer-kits , Normalizer-kit , Senior-vice-president , Sciences-business , Qiagen-expands-next-generation-sequencing-portfolio-with-qiaseq-normalizer-kits-ngs , Iaseq , Na , Gs-library , Iagen